Possible refinement of clinical thromboembolism assessment in patients with atrial fibrillation using echocardiographic parameters

Europace

Volumn 14, Issue 1, 2012, Pages 36-45

  Providência, Rui ^a   Botelho, Ana ^a   Trigo, Joana ^a   Quintal, Nuno ^a   Nascimento, José ^a   Mota, Paula ^a   Leitão Marques, António ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

Atrial fibrillation; CHA 2DS 2 VASc score; CHADS 2 score; Echocardiography; Risk stratification; Stroke

Indexed keywords

ADULT; AGED; ARTICLE; CROSS-SECTIONAL STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM THROMBOSIS; HEART LEFT ATRIUM; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; STROKE; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

AGED; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ELECTROCARDIOGRAPHY; FEMALE; HEART ATRIA; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RISK ASSESSMENT; ROC CURVE; STROKE; THROMBOEMBOLISM;

EID: 84055193010     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eur272     Document Type: Article

References (33)

1. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: Results from the National Registry of atrial fibrillation. JAMA 2001;285:2864-70. (Pubitemid 32537350)
2. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The euro heart survey on atrial fibrillation. Chest 2010; 137:263-72.
3. European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery, Camm AJ, Kirchhof P, Lip GY, Schotten U et al. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace 2010;12:1360-420.
4. Zabalgoitia M, Halperin JL, Pearce LA, Blackshear JL, Asinger RW, Hart RG. Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke prevention in atrial fibrillation III investigators. J Am Coll Cardiol 1998;31:1622-6. (Pubitemid 28273307)
5. Leung DY, Black IW, Cranney GB, Hopkins AP, Walsh WF. Prognostic implications of left atrial spontaneous echo contrast in nonvalvular atrial fibrillation. J Am Coll Cardiol 1994;24:755-62. (Pubitemid 24295753)
6. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography. Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. Ann Intern Med 1998;128: 639-47.
7. National Collaborating Centre for Chronic Conditions. Atrial Fibrillation: National Clinical Guideline for Management in Primary and Secondary Care. London: Royal College of Physicians; 2006. http://www.nice.org. uk/nicemedia/ pdf/CG036niceguideline.pdf (17 April 2011, date last accessed).
8. Poli D, Lip GY, Antonucci E, Grifoni E, Lane D. Stroke risk stratification in a 'real-world' elderly anticoagulated atrial fibrillation population. J Cardiovasc Electrophysiol 2011;22:25-30.
9. Olesen JB, Lip GY, Hansen ML, Hansen PR, Tolstrup JS, Lindhardsen J et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: Nationwide cohort study. BMJ 2011;342: D124.
10. Hughes M, Lip GY. Stroke and thromboembolism in atrial fibrillation: A systematic review of stroke risk factors, risk stratification schema and cost effectiveness data. Thromb Haemost 2008;99:295-394.
11. Stroke in AF working group. Independent predictors of stroke in patients with atrial fibrillation: A systematic review. Neurology 2007;69:546-54.
12. Pearce LA. Predictors of thromboembolism in atrial fibrillation: II echocardiographic features of patients at risk. Ann Int Med 1992;116:6-12.
13. Stroke Prevention in Atrial Fibrillation Investigators. Risk factors for thromboembolism during aspirin therapy in patients with atrial fibrillation: The Stroke Prevention in Atrial Fibrillation Study. J Stroke Cerebrovasc Dis 1995;5:147-57.
14. Aronow WS, Anh C, Kronzon I, Gutstein H. Risk factors for new thromboembolic stroke in patient =62 years of age with chronic atrial fibrillation. Am J Cardiol 1998;82:119-21. (Pubitemid 28322044)
15. Atrial Fibrillation Investigators: Atrial Fibrillation, Aspirin, Anticoagulation Study, European Atrial Fibrillation Study, Stroke Prevention in Atrial Fibrillation Study, Boston Area Anticoagulation Trial for Atrial Fibrillation Study, Canadian Atrial Fibrillation Study, Veterans Affairs Prevention in Atrial Fibrillation Study. Echocardiographic predictors of stroke in patients with atrial fibrillation: A prospective study of 1066 patients from 3 clinical trials. Arch In Med 1998;158:1316-20.
16. Aronow WS, Gutstein H, Hsieh FY. Risk factors for thromboembolic stroke in elderly patients with chronic atrial fibrillation. Am J Cardiol 1989;63:366-7. (Pubitemid 19049253)
17. Gerdts E, Wachtell K, Omvik P, Otterstad JE, Oikarinen L, Boman K et al. Left atrial size and risk of major cardiovascular events during antihypertensive treatment: Losartan intervention for endpoint reduction in hypertension trial. Hypertension 2007;49:311-6. (Pubitemid 46143006)
18. Stroke Risk in Atrial Fibrillation Working Group. Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation. Stroke 2008;39:1901-10.
19. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al. Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-63. (Pubitemid 41821197)
20. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al. Recommendations for chamber quantification. Eur J Echocardiogr 2006; 7:79-108. (Pubitemid 43257193)
21. Fatkin D, Kelly RP, Feneley MP. Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. J Am Coll Cardiol 1994;23:961-9. (Pubitemid 24090884)
22. Black IW, Hopkins AP, Lee LC, Walsh WF. Left atrial spontaneous echo contrast: A clinical and echocardiographic analysis. J Am Coll Cardiol 1991;18:398-404.
23. Daniel WG, Nellessen U, Schroder E, Nonnast-Daniel B, Bednarski P, Nikutta P et al. Left atrial spontaneous echo contrast in mitral valve disease: An indicator for an increased thromboembolic risk. J Am Coll Cardiol 1988;11:1204-11.
24. Handke M, Harloff A, Hetzel A, Olschewski M, Bode C, Geibel A. Predictors of left atrial spontaneous echocardiographic contrast or thrombus formation in stroke patients with sinus rhythm and reduced left ventricular function. Am J Cardiol 2005;96:1342-4. (Pubitemid 41505422)
25. Mahilmaran A, Nayar PG, Sudarsana G, Abraham K. Relationship of left atrial appendage function to left ventricular function. Indian Heart J 2004; 56:293-8. (Pubitemid 39551540)
26. Beppu S, Nimura Y, Sakaibara H, Nagata S, Park YD, Izumi S. Smoke-like echo in the left atrial cavity in mitral valve disease: Its features and significance. J Am Coll Cardiol 1985;6:744-9. (Pubitemid 16247619)
27. Siostrzonek P, Koppensteiner R, Gossinger H, Zangeneh M, Heinz G, Kreiner G et al. Hemodynamic and hemorheologic determinants of left atrial spontaneous echo contrast and thrombus formation in patients with idiopathic dilated cardiomyopathy. Am Heart J 1993;125:430-4. (Pubitemid 23055275)
28. Acar J, Michel PL, Cormier B, Vahanian A, Iung B. Features of patients with severe mitral stenosis with respect to atrial rhythm. Atrial fibrillation in predominant and tight mitral stenosis. Acta Cardiol 1992;47:115-24.
29. Kleemann T, Becker T, Strauss M, Schneider S, Seidl K. Prevalence and clinical impact of left atrial thrombus and dense spontaneous echo contrast in patients with atrial fibrillation and low CHADS2 score. Eur J Echocardiogr 2009;10:383-8.
30. Puwanant S, Varr BC, Shrestha K, Hussain SK, Tang WH, Gabriel RS et al. Role of the CHADS2 score in the evaluation of thromboembolic risk in patients with atrial fibrillation undergoing transesophageal echocardiography before pulmonary vein isolation. J Am Coll Cardiol 2009;54:2032-9.
31. Evans A, Perez I, Yu G, Kalra L. Secondary stroke prevention in atrial fibrillation: Lessons from clinical practice. Stroke 2000;31:2106-11.
32. Hart RG, Pearce LA, Miller VT, Anderson DC, Rothrock JF, Albers GW et al. Cardioembolic vs. noncardioembolic strokes in atrial fibrillation: Frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies. Cerebrovasc Dis 2000;10:39-43. (Pubitemid 30034856)
33. Yuan Z, Bowlin S, Einstadter D, Cebul RD, Conners AR Jr, Rimm AA. Atrial fibrillation as a risk factor for stroke: A retrospective cohort study of hospitalized Medicare beneficiaries. Am J Public Health 1998;88:395-400 (Pubitemid 28154940)